참고문헌
- Grossman H, Bergmann C, Parker S. Dementia: a brief review. Mt Sinai J Med. 2006;73:985-92
- Herholz K. PET studies in dementia. Ann Nucl Med 2003; 17:79-89 https://doi.org/10.1007/BF02988444
- DH Kim, Epidemiology of dementia in Korea. J Korean Med Assoc 2002;45:356-60 https://doi.org/10.5124/jkma.2002.45.4.356
- Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-79 https://doi.org/10.1111/j.1600-0447.1987.tb02906.x
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Forth edition(DSM-IV). Washington, DC : American Psychiatric Association. 1994
- Na DL. A clinical approach for patients with dementia. J Korean Med Assoc 2002;45:361-7 https://doi.org/10.5124/jkma.2002.45.4.361
- Y Jeong, DL Na. PET studies in Alzheimer disease and other degenerative dementias. Korean J Nucl Med 2003;37:13-23
- Saez-Fonseca JA, Lee L, Walker Z. Long-term outcome of depressive pseudodementia in the elderly. 2006 doi:10.1016/j.jad. 2006.11.004
- Silverman DH. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004;45:594-607
- MY Park. Differential diagnosis of vascular dementia and Alzheimer disease. J Korean Med Assoc 2002;45:392-400 https://doi.org/10.5124/jkma.2002.45.4.392
- Metter EJ, Mazziotta JC, Itabashi HH, Mankovich NJ, Phelps ME, Kuhl DE. Comparison of glucose metabolism, x-ray CT, and postmortem data in a patient with multiple cerebral infarcts. Neurology 1985;35:1695-701 https://doi.org/10.1212/WNL.35.12.1695
- Tedeschi E, Hasselbalch SG, Waldemar G, Juhler M, Hogh P, Holm S, Garde L, et al. Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1995;59:608-15 https://doi.org/10.1136/jnnp.59.6.608
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
- Alzheimer A. Uber eine eigenartige Erkrangkung der Hirnrinde, Allg Zeitschr Psychiatr Psychiatr-Gerichtl Med 1907;146-8
- Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20 https://doi.org/10.1212/WNL.43.1_Part_1.13
- Stern Y, Alexander GE, Prohovnik I, Stricks L, Link B, Lennon MC, Mayeux R. Relationship between lifetime occupation and parietal flow: implications for reserve against Alzheimer's disease pathology. Neurology 1995;45:55-60 https://doi.org/10.1212/WNL.45.1.55
- Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer's disease: a look to the future. Radiology 2003;226:315-36 https://doi.org/10.1148/radiol.2262011600
- Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur J Nucl Med Mol Imaging 2005;32:486-510 https://doi.org/10.1007/s00259-005-1762-7
- St George-Hyslop P. Molecular genetics of Alzheimer's disease. Biol Psychiatry 2000;47:183-99 https://doi.org/10.1016/S0006-3223(99)00301-7
- Tanzi R, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001;32:181-4 https://doi.org/10.1016/S0896-6273(01)00476-7
- Huang Y. Apolipoprotein E and Alzheimer disease. Neurology 2006;66(Suppl 1):S79-S85 https://doi.org/10.1212/01.wnl.0000192102.41141.9e
- Friedland RP, Fritsch T, Smyth KA, Koss E, Lerner AJ, Chen CH, Petot GJ, et al. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci U S A 2001;98:3440-5 https://doi.org/10.1073/pnas.061002998
- Grossman H. Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. CNS Spectr 2003;8:815-23 https://doi.org/10.1017/S1092852900019258
- Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530-8 https://doi.org/10.1001/archpsyc.63.5.530
- Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 2006;63:161-7 https://doi.org/10.1001/archpsyc.63.2.161
- Coleman RE. Positron emission tomography diagnosis of Alzheimer's disease. Neuroimag Clin N Am 2005;15:837-46 https://doi.org/10.1016/j.nic.2005.09.007
- Mayeux R, Sano M. Treatment of Alzheimer disease. New Engl J Med 2000;341:1670-9 https://doi.org/10.1056/NEJM199911253412207
- Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-53 https://doi.org/10.1212/WNL.56.9.1143
- Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, et al. Comparison of different MRI brain atrophy measures with clinical disease progression in AD. Neurology 2004;62:591-600 https://doi.org/10.1212/01.WNL.0000110315.26026.EF
- Minoshima S, Giordani B, Berent S. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94 https://doi.org/10.1002/ana.410420114
- Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, Schonknecht P , et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302-16 https://doi.org/10.1006/nimg.2002.1208
- Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92 https://doi.org/10.1001/archneur.58.12.1985
- Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-42 https://doi.org/10.1212/WNL.56.9.1133
- Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, et al. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:494-504 https://doi.org/10.1159/000017196
- Agdeppa ED, Kepe V, Liu J, Small GW, Huang SC, Petric A, Satyamurthy N, Barrio JR. 2-dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Mol Imaging Biol 2003;5: 404-17 https://doi.org/10.1016/j.mibio.2003.09.010
- Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388: 839-40 https://doi.org/10.1038/42166
- Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AAF. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996;47:462-6 https://doi.org/10.1212/WNL.47.2.462
- Imamura T, Ishii K, Sasaki M, Kitagaki H, Yamaji S, Hirono N, Shimomura T, Hashimoto M, Tanimukai S, Kazui H, Mori E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci. Lett. 1997;235:49-52 https://doi.org/10.1016/S0304-3940(97)00713-1
- Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001;50:358-65 https://doi.org/10.1002/ana.1133
- Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for severity. J Nucl Med 1997;38:797-802
- Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, et al. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Exp Neurol 2005;191(Suppl 1):S95-S103 https://doi.org/10.1016/j.expneurol.2004.06.017
- Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, Livingston G, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. 2002;73:134-40 https://doi.org/10.1136/jnnp.73.2.134
- Knibb JA, Kipps CM, Hodges JR. Frontotemporal dementia. Curr Opin Neurol 2006;19:565-71 https://doi.org/10.1097/01.wco.0000247606.57567.41
- Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-23 https://doi.org/10.1016/0167-4943(87)90022-7
- Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol 2003;49:13-9 https://doi.org/10.1159/000067021
- Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomized, controlled trial with trazodone. Dement Geriatr Cogn Disord 2004;17:355-9 https://doi.org/10.1159/000077171
- Hodges JR, Warlow CP. The etiology of transient global amnesia: a case-control study of 114 cases with prospective follow-up. Brain 1990;113:639-58 https://doi.org/10.1093/brain/113.3.639
- Josephs KA, Knopman DS, Whitwell JL, Boeve BF, Parisi JE, Petersen RC, Dickson DW. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs. FTLD-MND. Neurology 2005;65:645-7 https://doi.org/10.1212/01.wnl.0000173178.67986.7f
- Ferreri F, Agbokou C, Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson's disease. CMAJ 2006;175:1545-52 https://doi.org/10.1503/cmaj.060542
- Galvin JE. Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord 2006;20:302-10 https://doi.org/10.1097/01.wad.0000213858.27731.f8
- Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogenous degeneration involving the brain stem, basal gangliaand cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia dementia. Arch Neurol 1964;10:333-59 https://doi.org/10.1001/archneur.1964.00460160003001
- Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 1988;24: 399-406 https://doi.org/10.1002/ana.410240308
- Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm 1994;42:69-78
- Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117:1183-96 https://doi.org/10.1093/brain/117.5.1183
- Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995;186:17-20 https://doi.org/10.1016/0304-3940(95)11270-7
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-83 https://doi.org/10.1016/0092-8674(93)90585-E
- Geser F, Wenning GK. The diagnosis of multiple system atrophy. J Neurol 2006;253(Suppl 3):iii2-iii15 https://doi.org/10.1007/s00415-006-3002-x
- Quinn NP. How to diagnose multiple system atrophy. Mov Disord 2005;20(Suppl 12):S5-S10 https://doi.org/10.1002/mds.20534
- Gilman S, Low PA,Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ,Kaufmann H,Klockgether T, Lang AE, Lantos PL, Litvan I,Mathias CJ,Oliver E, Robertson D, Schatz I,Wenning GK. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 1998;74:189-92
- Park J, Ko HJ, Park YN, Jung CH. Dementia among the elderly in a, rural Korean community. British J Psychiat 1994;167:796-801
- Woo JI, Lee JH, Yoo KY, Kim CY, Kim YI, Shin YS. Prevalence estimation of dementia in a rural area of Korea. J Am Geriatr Soc 1998;46:983-7 https://doi.org/10.1111/j.1532-5415.1998.tb02753.x
- Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S10-S15
- Looi JC, Sachdev PS. Differentiation of vascular dementia from Alzheimer's disease on neuropsychological tests. Neurology 1999;53:670-8 https://doi.org/10.1212/WNL.53.4.670
- Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60 https://doi.org/10.1212/WNL.43.2.250
- Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000;59:23-30
- Jellinger KA. The enigma of mixed dementia. Alzheimer's and dementia 2007;3:40-53 https://doi.org/10.1016/j.jalz.2006.09.002
- Rockwood K, Bowler J, Erkinjuntti T, Hachinski V, Wallin A. Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S59-65 https://doi.org/10.1097/00002093-199912003-00010
- Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002;109:813-36 https://doi.org/10.1007/s007020200068
- Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004; 35(11 Suppl 1):2616-9 https://doi.org/10.1161/01.STR.0000143224.36527.44
- Haglund M, Sjobeck M, Englund E. Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia. Dement Geriatr Cogn Disord 2004;18:132-7 https://doi.org/10.1159/000079192
- Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277(10):813-7
- Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000;21:321-30 https://doi.org/10.1016/S0197-4580(00)00125-1
- Jellinger KA, Attems J. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurol Scand 2006;114:38-46 https://doi.org/10.1111/j.1600-0404.2006.00665.x
- Zanni GR, Wick JY. Differentiating dementias in long-term care patients. Consult Pharm 2007;22:14-6, 18, 21-8 https://doi.org/10.4140/TCP.n.2007.14
- Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999;156:675-82
- Hirono N, Mori E, Ishii K, Ikejiri Y, Imamura T, Shimomura T, et al. Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology 1998;50:380-3 https://doi.org/10.1212/WNL.50.2.380
- Guze BH, Baxter LR, Schwartz JM, Szuba MP, Mazziotta JC, Phelps ME. Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report. Psychiatry Res 1991;40:195-202 https://doi.org/10.1016/0165-1781(91)90158-L
- Mayberg HS. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 2003; 13:805-15 https://doi.org/10.1016/S1052-5149(03)00104-7
- Whybrow PC 1996 Behavioral and psychiatric aspects of hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The thyroid, ed 7. Philadelphia: Lippincott-Raven; 866-9
- Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A, Cosnard G, Melin J, Daumerie C. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metab 2001;86:3864-70 https://doi.org/10.1210/jc.86.8.3864